You are here

Researchers Explore How to End the Opioid Crisis at Web Event Tomorrow

PITTSBURGH, Oct. 23, 2019 /PRNewswire/ -- While major drug companies reached a $260 million settlement to avert a federal opioid trial this week, the crisis continues to impact Americans. Researchers at Duquesne University think they have some answers.

Here's How We Can End the Opioid Crisis will feature brief presentations from members of Duquesne's Chronic Pain Research Consortium, including:

  • Dr. Jelena Janjic, who created the first inflammatory pain nanomedicine that directly targets the pain source, which could significantly reduce the need for opioids in treating pain;
  • Dr. Ben Kolber, who is conducting research on creating a longer-lasting version of Narcan, which is used to revive individuals suffering an overdose;
  • Dr. Khalid Kamal, whose research focuses on the cost effectiveness and patient outcomes of alternatives to opioid treatments.

The 45-minute session will begin at 9:30 a.m. on Thursday, October 24. To view the presentation live, click here.

The session is part of Duquesne's Integrative Health Summit, which highlights the university's growing momentum in health sciences education and research. Other sessions will focus on new treatments for deadly diseases; children and family health issues, including the anti-vaccine movement; how integrative techniques help serve marginalized populations, including sexual assault victims and those dealing with violence-related trauma; and the role of the arts in medicine.

Earlier this year, Duquesne announced that it's creating a College of Osteopathic Medicine to help meet a looming physician shortage in the U.S.

Duquesne University
Founded in 1878, Duquesne is consistently ranked among the nation's top Catholic universities for its award-winning faculty and tradition of academic excellence. Duquesne, a campus of nearly 9,500 graduate and undergraduate students, has been nationally recognized for its academic programs, community service and commitment to sustainability. Follow Duquesne University on Facebook, Twitter and Instagram.


Cision View original content:

SOURCE Duquesne University